Maternal Stress, Early Life Factors and Infant Salivary Cortisol Levels.
PreventADALL
infant
perceived stress
salivary cortisol
Journal
Children (Basel, Switzerland)
ISSN: 2227-9067
Titre abrégé: Children (Basel)
Pays: Switzerland
ID NLM: 101648936
Informations de publication
Date de publication:
27 Apr 2022
27 Apr 2022
Historique:
received:
28
02
2022
revised:
09
04
2022
accepted:
20
04
2022
entrez:
28
5
2022
pubmed:
29
5
2022
medline:
29
5
2022
Statut:
epublish
Résumé
Salivary cortisol (SC), a commonly used biomarker for stress, may be disrupted by negative events in pregnancy, at birth and in infancy. We aimed to explore if maternal perceived stress (PSS) in or after pregnancy and SC levels in pregnancy were associated with SC in early infancy, and, secondly, to identify early life factors associated with infants' SC levels (iSC). At 3 months of age, SC was analyzed in 1057 infants participating in a Nordic prospective mother-child birth cohort study. Maternal PSS was available from questionnaires at 18- and 34-week gestational age (GA) and 3-month post-partum, and SC was analyzed at 18-week GA. Early life factors included sociodemographic and infant feeding from questionnaires, and birth data from medical charts. Associations to iSC were analyzed by Spearman correlation and multinomial logistic regression analyses. In this exploratory study neither PSS at any time point nor maternal SC (mSC) were associated with iSC. Higher birth weight was associated with higher levels of iSC, while inverse associations were observed in infants to a mother not living with a partner and mixed bottle/breastfeeding. Maternal stress was not associated with iSC levels, while birth weight, single motherhood and infant feeding may influence iSC levels.
Sections du résumé
BACKGROUND
BACKGROUND
Salivary cortisol (SC), a commonly used biomarker for stress, may be disrupted by negative events in pregnancy, at birth and in infancy. We aimed to explore if maternal perceived stress (PSS) in or after pregnancy and SC levels in pregnancy were associated with SC in early infancy, and, secondly, to identify early life factors associated with infants' SC levels (iSC).
METHODS
METHODS
At 3 months of age, SC was analyzed in 1057 infants participating in a Nordic prospective mother-child birth cohort study. Maternal PSS was available from questionnaires at 18- and 34-week gestational age (GA) and 3-month post-partum, and SC was analyzed at 18-week GA. Early life factors included sociodemographic and infant feeding from questionnaires, and birth data from medical charts. Associations to iSC were analyzed by Spearman correlation and multinomial logistic regression analyses.
RESULTS
RESULTS
In this exploratory study neither PSS at any time point nor maternal SC (mSC) were associated with iSC. Higher birth weight was associated with higher levels of iSC, while inverse associations were observed in infants to a mother not living with a partner and mixed bottle/breastfeeding.
CONCLUSIONS
CONCLUSIONS
Maternal stress was not associated with iSC levels, while birth weight, single motherhood and infant feeding may influence iSC levels.
Identifiants
pubmed: 35626800
pii: children9050623
doi: 10.3390/children9050623
pmc: PMC9139396
pii:
doi:
Types de publication
Journal Article
Langues
eng
Références
Proc Natl Acad Sci U S A. 2012 Oct 16;109 Suppl 2:17294-301
pubmed: 23045677
Int J Epidemiol. 2006 Oct;35(5):1146-50
pubmed: 16926217
J Psychosom Res. 2012 Apr;72(4):288-92
pubmed: 22405223
Asian Pac Isl Nurs J. 2020;5(3):128-138
pubmed: 33324730
Int Arch Allergy Immunol. 2014;163(3):215-24
pubmed: 24642608
Biol Res Nurs. 2018 Jan;20(1):54-62
pubmed: 29017336
Acta Paediatr. 2018 Jul;107(7):1205-1217
pubmed: 29405436
Biol Sex Differ. 2017 Jul 11;8(1):23
pubmed: 28693541
Psychoneuroendocrinology. 1998 Aug;23(6):613-6
pubmed: 9802131
J Eur Acad Dermatol Venereol. 2009 Jul;23(7):751-9
pubmed: 19646134
Children (Basel). 2021 Jul 30;8(8):
pubmed: 34438553
J Child Psychol Psychiatry. 2021 Nov 16;:
pubmed: 34787327
Int J Psychiatry Med. 2016 Apr;51(3):246-57
pubmed: 27284117
Scand J Clin Lab Invest. 2005;65(5):433-6
pubmed: 16081365
Psychoneuroendocrinology. 2010 Apr;35(3):329-38
pubmed: 19651476
Psychoneuroendocrinology. 1994;19(4):313-33
pubmed: 8047637
Lancet. 2020 Mar 21;395(10228):951-961
pubmed: 32087121
Int J Environ Res Public Health. 2020 Sep 21;17(18):
pubmed: 32967301
J Health Soc Behav. 1983 Dec;24(4):385-96
pubmed: 6668417
Bundesgesundheitsblatt Gesundheitsforschung Gesundheitsschutz. 2018 Aug;61(8):977-985
pubmed: 29934681
J Clin Nurs. 2021 Oct 26;:
pubmed: 34704296
Dev Psychopathol. 2021 Jul 02;:1-14
pubmed: 34210373
Int J Neurosci. 2004 Aug;114(8):933-45
pubmed: 15527200
ERJ Open Res. 2020 Oct 13;6(4):
pubmed: 33083440
Scand J Clin Lab Invest. 2003;63(4):303-10
pubmed: 12940639
Acta Paediatr. 2020 Dec;109(12):2594-2603
pubmed: 32274823
Pediatr Allergy Immunol. 2002;13(s15):11-3
pubmed: 12688617
Psychoneuroendocrinology. 2020 Aug;118:104716
pubmed: 32479967
J Child Psychol Psychiatry. 2011 Feb;52(2):119-29
pubmed: 20854366
Psychoneuroendocrinology. 2021 Mar;125:105106
pubmed: 33340919
Allergy. 2018 Oct;73(10):2063-2070
pubmed: 29710408
Clin Pediatr (Phila). 2010 Feb;49(2):158-65
pubmed: 20080522
PLoS One. 2015 Jun 18;10(6):e0129502
pubmed: 26086734
Int J Environ Res Public Health. 2020 Jul 28;17(15):
pubmed: 32731490
Psychosom Med. 2022 Apr 1;84(3):288-296
pubmed: 35067648
Biol Psychol. 2019 Oct;147:107614
pubmed: 30391479
J Pediatr. 2017 May;184:193-198.e3
pubmed: 28284475
Psychoneuroendocrinology. 2020 May;115:104603
pubmed: 32171123
Psychoneuroendocrinology. 2008 Apr;33(3):352-9
pubmed: 18207333
Child Dev. 2000 Jul-Aug;71(4):862-77
pubmed: 11016553
Psychoneuroendocrinology. 2007 May;32(4):358-66
pubmed: 17408865